Cargando…

Pre-eclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?

Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective...

Descripción completa

Detalles Bibliográficos
Autores principales: De Oliveira, Leandro Gustavo, Diniz, Angélica Lemos Debs, Prado, Caio Antônio de Campos, Cunha Filho, Edson Vieira Da, Souza, Francisco Lázaro Pereira De, Korkes, Henri Augusto, Ramos, José Geraldo, Costa, Maria Laura, Corrêa Junior, Mário Dias, Sass, Nelson, Cavalli, Ricardo De Carvalho, Martins-Costa, Sérgio Hofmeister De Almeida, Peraçoli, José Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183869/
https://www.ncbi.nlm.nih.gov/pubmed/33513638
http://dx.doi.org/10.1055/s-0040-1713803
Descripción
Sumario:Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective a difficult task. In addition, the costs related to screening protocols, the heterogeneity of the most affected populations and the lack of highly effective prevention methods reduce the potential of current available algorithms for screening. Thus, the National Specialized Commission of Hypertension in Pregnancy of the Brazilian Association of Gynecology and Obstetrics Federation (Febrasgo, in the Portuguese acronym) (NSC Hypertension in Pregnancy of the Febrasgo) considers that there are no screening algorithms to be implemented in the country to date and advocates that Aspirin and calcium should be widely used.